Research Articles | Page 26 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Jun 2023 Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution Apr 2019 Blood Aplastic Anemia
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings Apr 2023 Blood Myelodysplastic Syndromes (MDS)
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes Dec 2023 Blood Myelodysplastic Syndromes (MDS)
T cell dysfunctions in myelodysplastic syndromes Jan 2023 Blood Myelodysplastic Syndromes (MDS)
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) Apr 2020 Blood Myelodysplastic Syndromes (MDS)
Clinical decision‐making and treatment of myelodysplastic syndromes Oct 2023 Blood Myelodysplastic Syndromes (MDS)
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria May 2020 Blood Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood Myelodysplastic Syndromes (MDS)
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes Jan 2019 Blood Myelodysplastic Syndromes (MDS)